Filter Results:
(40)
Show Results For
- All HBS Web (40)
- Faculty Publications (7)
Show Results For
- All HBS Web (40)
- Faculty Publications (7)
←
Page 2 of 40
Results
- 01 Mar 2019
- News
The Blue-Green Revolution
volumes of goods and people long distances—humanity’s best bet might lie with overweight algae. And staving off the climate apocalypse could be just the beginning. That’s the premise underlying a decadelong joint effort to develop algae biofuel by ExxonMobil and... View Details
- 02 Apr 2013
- First Look
First Look: April 2
Publications 2006 Nature Reviews Beyond Magic Bullets: True Innovation in Health Care By: Narayan, Vaibhav A., Marco Mohwinckel, Gary Pisano, Michael Yang, and Husseini Manji Abstract—The molecular medicine revolution-based on advances in fields such as View Details
Keywords: Sean Silverthorne
- 01 Jun 2000
- News
The Business of Biotech
With the sequencing of the human genome running ahead of schedule (see sidebar), the American Stock Exchange's "BTK" biotech index registered an annual increase of 232 percent in February, prompting exuberant headlines ("Move Over,... View Details
Keywords: Julia Hanna
- 01 Sep 2008
- News
Mara Aspinall
of personalized medicine into clinical practice. Why does it seem that science is often so far ahead of practice in the medical field? Science has moved especially quickly in the last five years with the completion of the Human Genome... View Details
- 12 Nov 2015
- Research & Ideas
Can Consumers be Trusted with Their Own Health Care?
and a profile that varies by situation and according to the patient’s life stage.” Patient Empowerment Taken Too Far? As an example of patient empowerment—and a glimpse at its potential problems—Quelch talked about taking the 23andMe test, a saliva-based... View Details
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
when VC firm Mohr Davidow made an investment in Navigenics, a direct competitor to personal genomics company 23andMe, a startup it had invested in previously. A year later, a similar case occurred when Andreesen Horowitz cut its... View Details
- 03 Mar 2015
- First Look
First Look: March 3
we call entrepreneurial beacons. We argue that the actions or outcomes of salient organizations attract and motivate entrepreneurs, thus increasing the rate of foundings. To test this logic, we examine the impact of the Yale University... View Details
Keywords: Sean Silverthorne
- 07 Nov 2017
- First Look
New Research and Ideas: November 7, 2017
targeted therapies administered through IPG extended patient lifespans but increased overall costs. Now, in mid-2017, IPG is undergoing a major transition as it prepares to outsource the bulk of its genomic View Details
Keywords: Carmen Nobel
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
question—it’s clear.” Simply put, inefficiencies in the development of precision medicine can best be addressed by a business-analysis approach. With the mapping of the human genome completed 15 years ago, the sci-fi concept of using a... View Details
- 15 Feb 2000
- Research & Ideas
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. But when vying against others in industries where high uncertainty, long development... View Details
Keywords: by Judith A. Ross
- 01 Mar 2007
- News
Daniel Vasella
the test as he methodically refashioned the two old-line chemical companies with disparate corporate cultures into a single entity focused on health care and powered by an innovative approach to R&D. Today, Novartis is one of the world’s... View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
MORE Behind IBM's High-Risk Decision to Put Watson on Jeopardy MORE Behind IBM's High-Risk Decision to Put Watson on Jeopardy One day not long ago, a Japanese woman in her 60s walked into a hospital in Tokyo, worried she might have cancer. Doctors ran View Details
Keywords: Paul Kix; illustrations by Dan Page
- 11 Jun 2021
- News
The Power of Resilience
what my priorities are. I actually didn't know what that mission-driven work would be at the time. But I came across a company whose mission it was to democratize access to genetic testing for hereditary cancers. It was that power of... View Details
- 01 Mar 2003
- News
Inside the Revolution
develop across cultures, West was seeking a different science-driven commercial realm in which to test some of his semiconductor observations. In 1998, he began looking at the life sciences. “People in the industry were crying out for a... View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
for Google, etc. AI is already being used as an adjunct to diagnosis in some settings. However, the bar for US Food & Drug Administration approval for a diagnostic test is appropriately high, and “products” will need to meet this bar... View Details
- 10 Jan 2012
- First Look
First Look: January 10
a greater level of discretion to choose their interaction partners. Therefore, we expect to observe more homophilous interactions within these structures than across their boundaries. We test this argument using a dataset consisting of... View Details
Keywords: Sean Silverthorne
- 20 Oct 2009
- First Look
First Look: October 20
and test an empirical framework which allows us to separate selection from treatment effects of large shareholders. Individual blockholders tend to hold blocks in public firms located close to where they reside. Using this empirical... View Details
Keywords: Martha Lagace
- 15 Jul 2008
- First Look
First Look: July 15, 2008
that makes continual learning part of business as usual. Cases & Course MaterialsThe Broad Institute: Applying the Power of Genomics to Medicine Harvard Business School Case 608-114 In June 2003, Harvard University and MIT announced... View Details
Keywords: Martha Lagace